0001193125-18-178604 Sample Contracts

Applied Genetic Technologies Corporation Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales Agreement

Applied Genetic Technologies Corp • May 30th, 2018 • Biological products, (no disgnostic substances) • New York

• Company
  Applied Genetic Technologies Corp
• Filed
  May 30th, 2018
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

Applied Genetic Technologies Corporation, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows: